Sheila Garrity, JD, MPH, MBA, began as director of the HHS Office of Research Integrity (ORI) in March. As our offices work closely together to address research misconduct in NIH-funded biomedical research, we recently took some time to sit down and chat to get to know her better and welcome her to this new role.
Ms. Garrity has many outstanding credentials, with over 30 years supporting research integrity efforts within academia and professional societies. She previously led research integrity and responsible conduct of research efforts at Johns Hopkins University, George Washington University, and the Association for Research Integrity Officers (where she was a founding member and first president). When discussing her philosophy, she says, “Research integrity, we cannot just put it into a little box; we have to put it into our daily lives.” I agree.
“We have a responsibility, institutions, those that do what we do, to train the next generation of researchers…People know to do the right thing. You look at fabrication, falsification, and plagiarism. You’re basically telling people don’t lie, don’t cheat, don’t steal.”Sheila Garrity
Please join us for this brief conversation as we discuss:
- Her interest, vision, and priorities for supporting research integrity
- Working together to strengthen our educational efforts and other training resources
- Sharing data on managing allegations
- How emerging technologies may be used and when they may not (such as artificial intelligence during peer review)
- Reminders for recipients and researchers about their responsibilities
As a reminder, HHS ORI has the authority and the responsibility to review and monitor investigations of research misconduct allegations involving U.S. Public Health Service funding. When NIH receives an allegation of research misconduct, we review it and refer it to ORI as appropriate. More on NIH’s process for handling allegations is available on our Research Misconduct Overview webpage and also on ORI’s Handling Misconduct webpage.